EDITORIAL ....................................................................................................... 38
PŮVODNÍ PRÁCE
E. Růžička:
Extrapyramidové poruchy v neurologii a psychiatrii ...................................... 40
L. Velíšek:
Jak modelovat psychomotorické záchvaty? ........................................................ 47
M. Matoušek, A. Edman:
Vztah mezi sníženou vigilitou a projevy demence ........................................... 52
C. Škoda, P. Baudiš, T. Dostal, E. Dragomirecká, E. Johanovská, H. Papežová,
H. Svatoňová, D. Taussigová:
Mezinárodní studie schizofrenie koordinovaná Světovou zdravotnickou
organizací (ISoS) - II. Výsledky vyhledávání, ztráty .......................................... 56
I. Mazura, F. Koukolík, R. Jirák:
Molekulárnì genetická analýza Alzheimerovy
demence v èeské populaci I .................................................................................... 62
J. Praško, P. Baudiš, J. Klaschka:
Fototerapie v léčbě rekurentních unipolárních depresí. ................................ 65
PŘEHLEDNÉ ČLÁNKY
J. Šípek:
Principy KBT v ságách z úsvitu dìjin .................................................................. 70
Z. Matějček:
Typologie následků psychické deprivace ............................................................ 72
R. Balon:
Kulty z hlediska psychiatrie ................................................................................... 76
ZPRÁVY ............................................................................................................... 78
Přečetli jsme za vás ................................................................................................... 84
NOVÉ KNIHY ................................................................................................... 85
INFORMACE ..................................................................................................... 86

CONTENTS

EDITORIAL ....................................................................................................... 38
ORIGINAL PAPERS
E. Růžička:
Extrapyramidal Disorders in Neurology and Psychiatry ................................ 40
L. Velíšek:
How to Model Psychomotor Seizures? ................................................................ 47
M. Matoušek, A. Edman:
Relationship Between Lower Alertness Level and Symptoms of
Dementia..................................................................................................................... 52
C. Škoda, P. Baudiš, T. Dostal, E. Dragomirecká, E. Johanovská, H. Papežová,
H. Svatoňová, D. Taussigová:
WHO Coordinated International Study of Schizophrenia
II. Results of Tracing, Drop Outs ......................................................................... 56
I. Mazura, F. Koukolík, R. Jirák:
Molecular-Genetic Analysis of Alzheimer's Dementia in Czech
Population I: the Variability of Apolipoprotein E /Apo E/ ........................... 62
J. Praško, P. Baudiš, J. Klaschka:
Phototherapy in the Treatment of Reccurent Unipolar Depression .................................. 65
REVIEWS
J. Šípek:
Cognitive Behavioral Principles in Ancient Sagas ............................................ 70
Z. Matějček:
Typology of Psychic Deprivation Sequelae ........................................................ 72
R. Balon:
Cults in Psychiatric View ........................................................................................ 76
COMMUNICATIONS ......................................................................................... 78
We have read for you ................................................................................................ 84
NEW BOOKS ............................................................................................................ 85
INFORMATION ..................................................................................................... 86

EDITORIAL ................................................................................................................... 212
PŮVODNÍ PRÁCE
S. Kapur: Co nám říkají zobrazovací receptorové studie o léčbě schizofrenie? ..................... 213
L. Kubièka, Z. Dytrych, Z. Matìjèek, Z. Roth:
Prediktabilita psychosociálních charakteristik dospělých lidí na základì IQ
a osobnostních rysù zjištěných v dětském věku ............................................................... 216
Z. Klein, Z. Dáňová, P. Nepivoda, V. Peřina:
Dermatoglyfy rukou èeské populace - I. prstové vzory .........................................................223
PŘEHLEDNÉ ČLÁNKY
M. Valchář: Genetika a nemoci CNS ............................................................................... 231
J. Gut: Enuresis Nocturna - současné pohledy ................................................................ 238

KAZUISTIKY
M. Kolomazník, J. Hronek, J. Kolomazník, P. Kufner:
Sertralin v léčbě ejaculatio praecox: Intermitentnì nebo kontinuálnì? Příspěvek
k poznání mechanizmu účinku serotonergních preparátù ................................................... 244
O. Lang: Mýtus a psychoterapia.
Význam symbolov a mýtov v K.I.P. ................................................................................. 247
NOVÁ PSYCHOFARMAKA
J. Švestka: Antiepileptika III. generace a jejich použití v psychiatrii ................................ 250
ZPRÁVY ....................................................................................................................... 263
Přečetli jsme za Vás ......................................................................................................275
DOPISY, DISKUZE A OHLASY ..................................................................................... 283
NOVÉ KNIHY ............................................................................................................. 288
INFORMACE................................................................................................................ 290

CONTENTS

EDITORIAL ................................................................................................................... 212
ORIGINAL PAPERS
S. Kapur: What Receptor Imaging Studies Tell Us
About the Treatment of Schizophrenia? ........................................................................... 213
L. Kubička, Z. Dytrych, Z. Matějček, Z. Roth:
The Predictability of Adult Individuals' Psychosocial
Characteristics on the Basis of IQ and Personality
Traits Assessed in Childhood ......................................................................................... 216
Z. Klein, Z. Dáòová, P. Nepivoda, V. Peøina:
Dermatoglyphics of Hands in Czech Population
I. Fingertip Patterns .......................................................................................................223
REVIEWS
M. Valchář: Genetics and CNS Diseases ....................................................................... 231
J. Gut: Nocturnal Enuresis - Recent Opinions ................................................................ 238
CASE REPORTS
M. Kolomazník, J. Hronek, J. Kolomazník, P. Kufner:
Treatment of Premature Ejaculation with Sertraline:
Intermitently or Continuously? A Contribution
to Understanding the Mode of Action of Serotonergic Drugs ............................................. 244
O. Lang: Myth and Psychotherapy. Meaning of Symbols
and Myths in K.I.P. ....................................................................................................247
NEW PSYCHOTROPICS
J. Švestka: Anticonvulsants of the 3rd Generation in Psychiatry ...................................250
COMMUNICATIONS .............................................................................................. 263
We have read for you ............................................................................................. 275
CORRESPONDENCE, DISCUSSION....................................................................... 283
NEW BOOKS........................................................................................................ 288
INFORMATION........................................................................................................ 290

EDITORIAL ......................................................................................................... 152
PÙVODNÍ PRÁCE
M. Maršálek:
Mentální aspekty polékových extrapyramidových poruch .......................................... 154
J. Horáček, L. Motlová, J. Libiger, R. Bahbouh:
D-fenfluraminový test:  sonda serotoninergní neurotransmise..................................... 159
P. Weiss, J. Zvěřina:
Mimomanželské suxuální styky u obyvatel České republiky .................................... 164
KAZUISTIKY
V. Borecký:
Jan Lukeš .......................................................................................................... 167
NOVÁ PSYCHOFARMAKA
J. Švestka:
Nová psychofarmaka: Sertindol .............................................................................. 174
ZPRÁVY .............................................................................................................. 181
Přečetli jsme za Vás ............................................................................................ 197
DOPISY, DISKUZE A OHLASY ............................................................................ 202
NOVÉ KNIHY ...................................................................................................... 206
INFORMACE....................................................................................................... 208

EDITORIAL ........................................................................................................ 152
ORIGINAL PAPERS
M. Maršálek:
Mental Aspects of Drug-Induced Extrapyramidal Disorders .................................... 154
J. Horáček, L. Motlová, J. Libiger, R. Bahbouh:
D-Fenfluramine Challenge Test - The Probe for Serotoninergic Neurotransmission .....159
P. Weiss, J. Zvěřina:
Extramarital Sex in the Czech Republic:
Results of a National Survey ............................................................................... 164
CASE REPORTS
V. Borecký:
Jan Lukeš ........................................................................................................... 167
NEW PSYCHOTROPICS
J. Švestka:
New Antipsychotics: Sertindol ............................................................................... 174
COMMUNICATIONS ............................................................................................. 181
We have read for you ............................................................................................ 197
CORRESPONDENCE, DISCUSSION .................................................................... 202
NEW BOOKS....................................................................................................... 206
INFORMATION .................................................................................................... 208

EDITORIAL ........................................................................................................... 62
PŮVODNÍ PRÁCE
J. Libiger, J. Švestka a český tým hodnotitelù studie:
Olanzapin verzus haloperidol: Výsledky akutní fáze dvojitì slepé
studie úèinnosti nového atypického neuroleptika u pacientù se
schizofrenní a schizoafektivní psychózou.............................................................. 64
J. Židovská, Š. Růžičková, M. Vojtíšková, E. Havrdová, J. Roth, J. Kapras:
DNA analýza genu Huntingtonovy choroby v české populaci .................................. 70
J. Bečka, E. Nagyová, J. Horáček:
Charakteristiky snù u vybraných duševních onemocnění .......................................... 74
PŘEHLEDNÉ ČLÁNKY
C. Höschl: Teorie deprese ................................................................................... 78
M. Alda: Co nového v genetickém výzkumu maniodepresivity? ................................ 86
P. Mohr: Deficitní syndrom ve schizofrenii: pøehled ................................................ 94
R. Rokyta: Bolest a její patofyziologie ................................................................ 103
J. Patočka, M. Tichý, D. Řípová, R. Jirák: Apolipoprotein E
jako rizikový faktor demence .............................................................................. 108
KAZUISTIKY
L. Motlová: Olanzapin v léèbì schizofrenie ........................................................... 112
NOVÁ PSYCHOFARMAKA
J. Švestka:
Nová antipsychotika II. generace: Olanzapin ....................................................... 115
ZPRÁVY ......................................................................................................... 124
Přečetli jsme za Vás ....................................................................................... 138
DOPISY, DISKUZE A OHLASY.......................................................................... 143
NOVÉ KNIHY.................................................................................................... 147
INFORMACE ................................................................................................... 149

EDITORIAL ....................................................................................................... 62
ORIGINAL PAPERS
J. Libiger, J. Švestka and the Czech team of study evaluators:
Olanzapine Versus Haloperidol: Acute Phase Results
of the Double Blind Randomized Clinical Study of Efficacy
of a New Atypical Antipsychotic in Patients with
Schizophrenia and Schizoaffective Psychosis ...................................................... 64
J. Židovská, Š. Růžičková, M. Vojtíšková, E. Havrdová, J. Roth, J. Kapras:
DNA analysis of the Huntington's Disease Gene
in the Czech Population ..................................................................................... 70
J. Bečka, E. Nagyová, J. Horáček:
Dream Characteristics in Selected Mental Disorders ............................................ 74
REVIEWS
C. Höschl: Theory of Depression ........................................................................ 78
M. Alda: What is New in Genetic Research of Bipolar Illness ................................ 86
P. Mohr: Deficit Syndrome of Schizophrenia: A Review ........................................ 94
R. Rokyta: Pain and its Pathophysiology ......................................................... 103
J. Patočka, M. Tichý, D. Řípová, R. Jirák: Apolipoprotein E
as a Risk Factor of Dementia ........................................................................... 108
CASE REPORTS
L. Motlová: Olanzapine in the Treatment of Schizophrenia .................................... 112
NEW PSYCHOTROPICS
J. Švestka:
New Antipsychotics of the 2nd generation: Olanzapine ....................................... 115
COMMUNICATIONS ........................................................................................ 124
We have read for you ....................................................................................... 138
CORRESPONDENCE, DISCUSSION................................................................. 143
NEW BOOKS ................................................................................................. 147
INFORMATION ............................................................................................... 149